RAPT Therapeutics, Inc.
Chemokine receptor modulators and uses thereof
Last updated:
Abstract:
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.
Status:
Grant
Type:
Utility
Filling date:
19 Nov 2018
Issue date:
31 Mar 2020